Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 217
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The State of the Psychedelic Industry & Open Questions (Video)
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results...
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in...
PT269 – Adam Strauss – Comedy, OCD, and The Mushroom Cure
Psychedelic Research Bulletin: October 2021
The Compounds in Psychedelic Cacti
atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort...
Red Light Holland Appoints New Chief Financial Officer
PharmaDrug Expands Product Offering to Prepare for Potential Adult Use Market...
Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT...
Psychedelic Bulletin: MindMed Announces R(-)-MDMA Program; Psilocybin for Anxiety Study Secures...
Load more
